Position in RGC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$134,199
-$542,569 QoQ
Shares Held
22,036
-17.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 35 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RGC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $151,394,819 across 40 Drug Manufacturers - Specialty & Generic names. RGC ranks #36 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
633,370 | $45,513,968 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
48,656 | $26,363,280 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
617,308 | $21,402,068 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
140,059 | $8,956,773 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
44,143 | $7,439,861 | |
| 6 | ALKS |
Alkermes plc.
|
115,195 | $6,036,218 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
133,225 | $3,278,667 | |
| 8 | HROW |
Harrow, Inc.
|
73,622 | $3,126,726 |
All Filings in RGC
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $134,199 | 22,036 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $676,768 | 26,613 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $546,231 | 26,011 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $791,797 | 51,249 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,701,324 | 99,843 | Shares | Defined | 2025-08-27 | |
| No filing history on record for this holder in this stock. | ||||||